Skip to main content

REVIEW article

Front. Oncol.
Sec. Pharmacology of Anti-Cancer Drugs
Volume 14 - 2024 | doi: 10.3389/fonc.2024.1507958

RESEARCH PROGRESS OF NOVEL ANTI-TUMOR DRUG FORMULATIONSPREPARATIONS

Provisionally accepted
Yan Liu Yan Liu 1Qie Guo Qie Guo 2Yunyan Shi Yunyan Shi 2Mengna Cui Mengna Cui 2*Fanbo Jing Fanbo Jing 2*
  • 1 Qingdao University, Qingdao, China
  • 2 The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China

The final, formatted version of the article will be published soon.

    Cancers have become the second leading cause of death worldwide, following cardiovascular diseases.deadliest disease in the world after cardiovascular disease.TheTraditional anti-cancer strategies, includingwere long dominated by radiotherapy and chemotherapy, surgery, and targeted drugstherapies, etc., however, which have been widely used but are often reassessed due to their significant for the side effects and relatively low cure rate. At presentRecently, the developmentemerging of new novel formulationspreparations of for anti-tumor drugs has gained considerablenot only attracted attention, marking a pivotal step forward in cancer treatment advancements.but has also turned a new page for the improvements and advances in the treatment of cancers. These innovative formulations aim to enhance the therapeutic efficacy of anti-tumor drugs by employing advanced drug formulation technologies and delivery systems. In particular, nano-drug delivery systems (NDDS) have emerged as a promising approach to improve drug targeting, reduce side effects, and overcome drug resistance. This review highlights recent progress in NDDS for anti-tumor drug development and explores the future prospects of these advanced formulations in improving cancer treatment outcomes.In particular, new anti-tumor drug formulations refer to methods that improve the therapeutic effects of anti-tumor drugs via using different drug formulation technologies and delivery systems. In this review, we summarize the research progress of nano-drug delivery systems(NDDS) in new antitumor drugs in, and anticipate the prospect of new anti-tumor drug preparations in the future.

    Keywords: Cancer, Anti-tumor drug, Nano-drug delivery systems, New Formulations, Nanomedicine

    Received: 08 Oct 2024; Accepted: 02 Dec 2024.

    Copyright: © 2024 Liu, Guo, Shi, Cui and Jing. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Mengna Cui, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong Province, China
    Fanbo Jing, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong Province, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.